Colagiuri B, Park J, Barnes K, Sharpe L, Boakes R A, Colloca L, Livesey E J
School of Psychology, University of Sydney, NSW, Australia.
School of Psychology, University of Sydney, NSW, Australia.
J Pain. 2021 Jul;22(7):864-877. doi: 10.1016/j.jpain.2021.02.008. Epub 2021 Feb 23.
Nocebo hyperalgesia is a pervasive problem that significantly adds to the burden of pain. Conditioning is a key mechanism of nocebo hyperalgesia and recent evidence indicates that, once established, nocebo hyperalgesia is resistant to extinction. This means that preventive strategies are critical. We therefore tested whether two novel strategies - overshadowing (Experiment 1) and pre-exposure (Experiment 2) - could inhibit conditioned nocebo hyperalgesia. Overshadowing involves introducing additional cues during conditioning that should compete with and overshadow learning about the target nocebo cue. Pre-exposure involves pre-exposing the target nocebo cue in the absence of pain, which should diminish its ability to become associated with pain later. In both studies, healthy volunteers (N = 141) received exposure to a series of electrocutaneous pain stimuli with and without a sham electrode 'activated', which they were led to believe was a genuine hyperalgesic treatment. Nocebo conditioning was achieved by pairing sham activation with high pain prior to testing at equivalent pain intensity. In both studies, standard nocebo conditioning led to clear nocebo hyperalgesia relative to natural history controls. In Experiment 1, there was no evidence that overshadowing attenuated nocebo hyperalgesia. Importantly, however, Experiment 2 found that pre-exposure successfully attenuated nocebo hyperalgesia with post hoc analysis suggesting that this effect was dose-dependent. These findings provide novel evidence that pre-exposure, but not overshadowing, could be a cheap and effective way for mitigating the substantial harm caused by conditioned nocebo hyperalgesia in clinical settings. PERSPECTIVE: Nocebo hyperalgesia causes substantial patient burden with few preventive options available. Our study found novel evidence that pre-exposing treatment cues without pain, but not overshadowing them with other cues, has the capacity to inhibit conditioned nocebo hyperalgesia. Pre-exposure may therefore be an effective preventive strategy to combat nocebo hyperalgesia.
反安慰剂高敏是一个普遍存在的问题,它显著增加了疼痛负担。条件作用是反安慰剂高敏的关键机制,最近的证据表明,一旦形成,反安慰剂高敏就难以消退。这意味着预防策略至关重要。因此,我们测试了两种新策略——遮蔽(实验1)和预暴露(实验2)——是否可以抑制条件性反安慰剂高敏。遮蔽是指在条件作用过程中引入额外的线索,这些线索应与目标反安慰剂线索竞争并遮蔽对其的学习。预暴露是指在没有疼痛的情况下预先暴露目标反安慰剂线索,这应会降低其日后与疼痛建立关联的能力。在两项研究中,健康志愿者(N = 141)接受了一系列电皮肤疼痛刺激,其中有无“激活”的假电极,他们被引导相信这是一种真正的高敏治疗。通过在等效疼痛强度测试前将假激活与高疼痛配对来实现反安慰剂条件作用。在两项研究中,相对于自然病程对照组,标准的反安慰剂条件作用导致了明显的反安慰剂高敏。在实验1中,没有证据表明遮蔽能减轻反安慰剂高敏。然而,重要的是,实验2发现预暴露成功减轻了反安慰剂高敏,事后分析表明这种效应是剂量依赖性的。这些发现提供了新的证据,即预暴露而非遮蔽可能是一种廉价且有效的方法,可减轻临床环境中条件性反安慰剂高敏造成的重大危害。观点:反安慰剂高敏给患者带来了沉重负担,且几乎没有可用的预防方法。我们的研究发现了新的证据,即无疼痛地预先暴露治疗线索,而非用其他线索遮蔽它们,有能力抑制条件性反安慰剂高敏。因此,预暴露可能是对抗反安慰剂高敏的一种有效预防策略。